The role of F-18-FDG PET/CT in detecting colorectal cancer recurrence in patients with elevated CEA levels

ÖZKAN E., SOYDAL Ç., ARAZ M., KIR K. M., İBİŞ E.

NUCLEAR MEDICINE COMMUNICATIONS, vol.33, no.4, pp.395-402, 2012 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 33 Issue: 4
  • Publication Date: 2012
  • Doi Number: 10.1097/mnm.0b013e32834f7dbe
  • Journal Name: NUCLEAR MEDICINE COMMUNICATIONS
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.395-402
  • Keywords: carcinoembryonic antigen, colorectal carcinoma, fluorine-18 fluorodeoxyglucose PET/computed tomography, CARCINOEMBRYONIC ANTIGEN CEA, CURATIVE RESECTION, POSTOPERATIVE SURVEILLANCE, FDG PET/CT, COLON, PATTERNS, RECTUM, ADENOCARCINOMA, CARCINOMA
  • Ankara University Affiliated: Yes

Abstract

Introduction In this study we aimed to define the success of fluorine-18 (F-18) fluorodeoxyglucose (FDG) PET/computed tomography (PET/CT) in detecting recurrent disease in our patient group with colorectal cancer (CRC) and elevated carcinoembryonic antigen (CEA) levels.